Erika Carmel-Tech Ltd (TA:ERKA) — Market Cap & Net Worth
Market Cap & Net Worth: Erika Carmel-Tech Ltd (ERKA)
Erika Carmel-Tech Ltd (TA:ERKA) has a market capitalization of $5.82 Million (ILA2.17 Billion) as of May 22, 2026. Listed on the TA stock exchange, this Israel-based company holds position #28240 globally and #407 in its home market, demonstrating a 9.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Erika Carmel-Tech Ltd's stock price ILA52.10 by its total outstanding shares 41666116 (41.67 Million). Analyse ERKA cash flow metrics to see how efficiently the company converts income to cash.
Erika Carmel-Tech Ltd Market Cap History: 2026 to 2026
Erika Carmel-Tech Ltd's market capitalization history from 2026 to 2026. Data shows growth from $5.82 Million to $5.82 Million (0.00% CAGR).
Erika Carmel-Tech Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Erika Carmel-Tech Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ERKA by Market Capitalization
Companies near Erika Carmel-Tech Ltd in the global market cap rankings as of May 22, 2026.
Key companies related to Erika Carmel-Tech Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $152.62 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #198 globally with a market cap of $119.97 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #257 globally with a market cap of $97.77 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $152.62 Billion | $87.77 |
| #198 | Stryker Corporation | NYSE:SYK | $119.97 Billion | $313.50 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #257 | Medtronic PLC | NYSE:MDT | $97.77 Billion | $78.15 |
Erika Carmel-Tech Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, Erika Carmel-Tech Ltd's market cap moved from $5.82 Million to $ 5.82 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA5.82 Million | -- |
End of Day Market Cap According to Different Sources
On May 22nd, 2026 the market cap of Erika Carmel-Tech Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.82 Million USD |
| MoneyControl | $5.82 Million USD |
| MarketWatch | $5.82 Million USD |
| marketcap.company | $5.82 Million USD |
| Reuters | $5.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Erika Carmel-Tech Ltd
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. T… Read more